Shares of DaVita Inc. DVA slid 0.01% to $161.57 Tuesday, on what proved to be an all-around positive trading session for the ...

DaVita HealthCare (DVA) concluded the recent trading session at $161.57, signifying a -0.01% move from its prior day's close.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

DaVita stock is Tuesday's IBD Stock Of The Day. Shares have lingered in a buy zone for a month, buoyed by strong earnings ...

Javier Rodriguez, Chief Executive Officer at DaVita DVA, reported an insider sell on September 17, according to a new SEC filing. Tracking the Wednesday's morning session, DaVita shares are trading at ...

DaVita Inc. (DVA), a provider of kidney care services, announced on Friday that it has appointed David Maughan as Chief Operating ...

In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on DaVita (DVA – Research Report), with a price target ...

DENVER, Sept. 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that David Maughan will assume the role of chief operating officer. This appointment ...

肾脏护理服务领先提供商DaVita Inc. (NYSE:DVA)宣布，自2024年9月15日起，任命David P. Maughan为DaVita肾脏护理新任首席运营官。Maughan将接替Michael D. Staffieri，后者将从同一日期起担任荣誉首席运营官。

DaVita Inc. closed $4.46 below its 52-week high ($166.04), which the company reached on September 19th.